Pharmaceutical News and Articles

New Model Performs Well for Detecting Alcohol-Associated Liver Disease

A novel predictive model demonstrates good performance for detecting metabolic dysfunction and alcohol-associated liver disease (MetALD) and alcohol-associated

Predictors of Prediabetes/T2DM Identified Among U.S. Adolescents

Male gender, younger age, and waist-to-height ratio are independent predictors of prediabetes type 2 diabetes mellitus (T2DM) among U.S. adolescents, according

Excess Prepregnancy Parental Adiposity Linked to Offspring MASLD

Prepregnancy parental overweight or obesity is associated with increased odds of offspring metabolic dysfunction-associated steatotic liver disease (MASLD) in a

Twenty Percent of Eligible Youth Prescribed GLP-1 Receptor Agonists

Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the odds of prescription higher with inc

Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)

Genentech, a member of the Roche Group (SIX RO, ROG OTCQX RHHBY), announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its p

Theravance Biopharma Reports Phase 3 CYPRESS Study of Ampreloxetine Did Not Meet Primary Endpoint

Theravance Biopharma, Inc. ( Theravance Biopharma or the Company ) (NASDAQ TBPH) today announced topline results from the Phase 3 CYPRESS study evaluating the e

Johnson & Johnson Therapy Nipocalimab Granted U.S. FDA Fast Track Designation in Systemic Lupus Erythematosus (SLE)

SPRING HOUSE, Pa., (March 3, 2026) Johnson Johnson (NYSE JNJ) today announced that nipocalimaba was granted U.S. Food and Drug Administration (FDA) Fast Track d

Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera

Chiesi Global Rare Diseases Announces FDA Approval of Juxtapid (lomitapide) Capsules for Pediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)

Sex, Menopausal Status Tied to Severity of Early Lyme Disease Presentation

Sex and menopausal status appear to impact serologic status and severity of early Lyme disease, according to a study published online Feb. 7 in Clinical and Exp